Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?
Department of Paediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Jamie N
JN
Frediani
Centre for Reviews and Dissemination, University of York, York, UK.
Bob
http://orcid.org/0000-0002-4938-9673
B
Phillips
D055499:Catheter-Related Infections / Q000209:etiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology*; D013997:Time Factors
Clinical Procedures; Evidence Based Medicine; Haematology; Infectious Diseases